The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Open accessAbstract
Alzheimer's disease (AD) is a main cause of dementia, accounting for up to 75% of all dementia cases. Pathophysiological processes described for AD progression involve neurons and synapses degeneration, mainly characterized by cholinergic impairment. This feature makes acetylcholinesterase inhibitors (AChEi) the main class of drugs currently used for the treatment of AD dementia phase, among which galantamine is the only naturally occurring substance. However, several plant species producing diverse classes of alkaloids, coumarins, terpenes, and polyphenols have been assessed for their anti-AChE activity, becoming potential candidates for new anti-AD drugs. Therefore, this mini-review aimed to recapitulate last decade studies on the anti-AChE activity of plant species, their respective extracts, as well as isolated compounds. The anti-AChE activity of extracts prepared from 54 plant species pertaining 29 families, as well as 36 isolated compounds were classified and discussed according to their anti-AChE pharmacological potency to highlight the most prominent ones. Besides, relevant limitations, such as proper antioxidant assessment, and scarcity of toxicological and clinical studies were also discussed in order to help researchers out with the bioprospection of potentially new AChEi.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611
(2015) · HAL · Cited by 2,238
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Acetylcholinesterase: From 3D structure to function
Dvir, H., Silman, I., Harel, M., Rosenberry, T. L., & Sussman, J. L. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.042 · Cited by 790
A review on cholinesterase inhibitors for Alzheimer’s disease
Anand, P., & Singh, B. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0036-3 · Cited by 709
Acetylcholinesterase inhibitors from plants and fungi
Houghton, P. J., Ren, Y., & Howes, M.-J. (2006) · Natural Product Reports · doi:10.1039/b508966m · Cited by 584
A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease
Anand, P., Singh, B., & Singh, N. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.042 · Cited by 527
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
Shu, Y.-Z. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 517
Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
Craig, L. A., Hong, N. S., & McDonald, R. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.001 · Cited by 486
The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity
Liu, J.-S., Zhu, Y.-L., Yu, C.-M., Zhou, Y.-Z., Han, Y.-Y., Wu, F.-W., & Qi, B.-F. (1986) · Canadian Journal of Chemistry · doi:10.1139/v86-137 · Cited by 473
The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
Tarawneh, R., & Holtzman, D. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006148 · Cited by 471
Therapeutic strategies for Alzheimer's disease in clinical trials
Godyń, J., Jończyk, J., Panek, D., & Malawska, B. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2015.07.006 · Cited by 452
New Acetylcholinesterase Inhibitors for Alzheimer's Disease
Mehta, M., Adem, A., & Sabbagh, M. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/728983 · Cited by 436
Anticholinergic effects of medication in elderly patients.
Tune, L. E. (2001) · PubMed · Cited by 400
Perry, N. S. L., Bollen, C., Perry, E. K., & Ballard, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00108-4 · Cited by 383
Ingkaninan, K., Temkitthawon, P., Chuenchom, K., Yuyaem, T., & Thongnoi, W. (2003) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2003.08.008 · Cited by 366
Berberis Vulgaris and Berberine: An Update Review
Imenshahidi, M., & Hosseinzadeh, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5693 · Cited by 359
Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts
López, S., Bastida, J., Viladomat, F., & Codina, C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02034-9 · Cited by 358
Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Murray, A., Faraoni, M., Castro, M., Alza, N., & Cavallaro, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040004 · Cited by 341
Johnson, G., & Moore, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775193127 · Cited by 321
Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution
Greenblatt, H. M., Kryger, G., Lewis, T., Silman, I., & Sussman, J. L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01637-3 · Cited by 310
Anti-Alzheimer and Antioxidant Activities of Coptidis Rhizoma Alkaloids
Jung, H. A., Min, B.-S., Yokozawa, T., Lee, J.-H., Kim, Y. S., & Choi, J. S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1433 · Cited by 307
Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
Khan, H., Marya, Amin, S., Kamal, M. A., & Patel, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.007 · Cited by 307
Hamidpour, M., Hamidpour, R., Hamidpour, S., & Shahlari, M. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.130373 · Cited by 300
(2005) · Humana Press eBooks · doi:10.1385/1592599559 · Cited by 300
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293
Huperzine A from Huperzia species—An ethnopharmacolgical review
Ma, X., Tan, C., Zhu, D., Gang, D. R., & Xiao, P. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.05.030 · Cited by 291
Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Subhan, F., & Ahmed, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00168 · Cited by 281
Fiest, K. M., Roberts, J. I., Maxwell, C. J., Hogan, D. B., Smith, E. E., Frolkis, A., Cohen, A., Kirk, A., Pearson, D., Pringsheim, T., et al. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.36 · Cited by 272
Akhondzadeh, S., Shafiee Sabet, M., Harirchian, M. H., Togha, M., Cheraghmakani, H., Razeghi, S., Hejazi, S. S., Yousefi, M. H., Alimardani, R., Jamshidi, A., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1706-1 · Cited by 268
Takizawa, C., Thompson, P. L., van Walsem, A., Faure, C., & Maier, W. C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141134 · Cited by 252
A phase II trial of huperzine A in mild to moderate Alzheimer disease
Rafii, M. S., Walsh, S., Little, J. T., Behan, K., Reynolds, B., Ward, C., Jin, S., Thomas, R., Aisen, P. S., & Study, F. T. A. D. C. (2011) · Neurology · doi:10.1212/wnl.0b013e318216eb7b · Cited by 240
Schrattenholz, A., Pereira, E. F., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226
Kang, S. Y., Lee, K. Y., Sung, S. H., Park, M. J., & Kim, Y. C. (2001) · Journal of Natural Products · doi:10.1021/np000441w · Cited by 218
Rollinger, J. M., Hornick, A., Langer, T., Stuppner, H., & Prast, H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049655r · Cited by 211
Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
Thomsen, T., & Kewitz, H. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90429-u · Cited by 207
Synaptic pathology: A shared mechanism in neurological disease
Henstridge, C. M., Pickett, E., & Spires-Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 174
Methods To Measure the Antioxidant Activity of Phytochemicals and Plant Extracts
Amorati, R., & Valgimigli, L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01079 · Cited by 174
Flavonoids as Acetylcholinesterase Inhibitors
Uriarte-Pueyo, I., & I. Calvo, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798184325 · Cited by 164
Natural Product Inhibitors of Acetylcholinesterase
Hostettmann, K., Borloz, A., Urbain, A., & Marston, A. (2006) · Current Organic Chemistry · doi:10.2174/138527206776894410 · Cited by 152
Sahoo, A. K., Dandapat, J., Dash, U. C., & Kanhar, S. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.12.015 · Cited by 148
Ovais, M., Ayaz, M., Khalil, A. T., Shah, S. A., Jan, M. S., Raza, A., Shahid, M. M., & Shinwari, Z. K. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2057-9 · Cited by 148
Blanco-Silvente, L., Cervelló, X. C., Sáez, M., Barceló, M. A., Garre‐Olmo, J., Franch, J. V., & Capellà, D. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx012 · Cited by 147
Ayaz, M., Junaid, M., Ahmed, J., Ullah, F., Sadiq, A., Ahmad, S., & Imran, M. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-145 · Cited by 143
Adewusi, E., & Steenkamp, V. (2011) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(11)60203-4 · Cited by 139
Ayaz, M., Junaid, M., Ullah, F., Sadiq, A., Khan, M. A., Ahmad, W., Shah, M. R., Imran, M., & Ahmad, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0145-8 · Cited by 132
The Psychopharmacology of European Herbs with Cognition-Enhancing Properties
Kennedy, D. O., & Scholey, A. B. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010387 · Cited by 124
Toxicology effects of saffron and its constituents: a review.
Bostan, H. B., Mehri, S., & Hosseinzadeh, H. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8230 · Cited by 124
Ha, G. T., Wong, R. K., & Zhang, Y. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201000269 · Cited by 114
Pereira, D. M., Ferreres, F., Oliveira, J. M. A., Gaspar, L., Faria, J. R. C., Valentão, P., Sottomayor, M., & Andrade, P. B. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.10.008 · Cited by 106
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
Qian, Z., & Ke, Y. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00216 · Cited by 106
Ahmad, S., Ullah, F., Sadiq, A., Ayaz, M., Imran, M., Ali, I., Zeb, A., Ullah, F., & Shah, M. R. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-0998-z · Cited by 103
Ahmad, S., Ullah, F., Ayaz, M., Sadiq, A., & Imran, M. (2015) · Biological Research · doi:10.1186/s40659-015-0010-2 · Cited by 95
Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
Damar, U., Gersner, R., Johnstone, J. T., Schachter, S. C., & Rotenberg, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1175303 · Cited by 94
Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L.
Dastmalchi, K., Ollilainen, V., Lackman, P., af Gennäs, G. B., Dorman, H. J. D., Järvinen, P. P., Yli‐Kauhaluoma, J. T., & Hiltunen, R. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.11.034 · Cited by 91
Ali, S. K., Hamed, A. R., Soltan, M. M., Hegazy, U. M., Elgorashi, E. E., El-Garf, I. A., & Hussein, A. A. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-121 · Cited by 91
Orhan, İ. E., Orhan, G., & Gürkaş, E. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711796575434 · Cited by 87
Kamal, Z., Ullah, F., Ayaz, M., Sadiq, A., Ahmad, S., Zeb, A., Hussain, A., & Imran, M. (2015) · Biological Research · doi:10.1186/s40659-015-0011-1 · Cited by 86
Heinrich, M. (2010) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/s1099-4831(10)06804-5 · Cited by 85
Cortés, N., Posada‐Duque, R., Álvarez, R., Álzate, F., Berkov, S. H., Cardona‐Gómez, G. P., & Osorio, E. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.011 · Cited by 85
Jung, H. A., Ali, M. Y., Jung, H. J., Jeong, H. O., Chung, H. Y., & Choi, J. S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.06.037 · Cited by 84
Investigating the Antioxidant and Acetylcholinesterase Inhibition Activities of Gossypium herbaceam
Zhao, Y., Dou, J., Wu, T., & Aisa, H. A. (2013) · Molecules · doi:10.3390/molecules18010951 · Cited by 81
Loizzo, M. R., Tundis, R., Conforti, F., Menichini, F., Bonesi, M., Nadjafi, F., Frega, N. G., & Menichini, F. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.09.016 · Cited by 81
Natural Products as Sources of New Lead Compounds for the Treatment of Alzheimer’s Disease
Huang, L., Su, T., & Li, X. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990142 · Cited by 81
Cardoso-Lopes, E. M., Maier, J. A., da Silva, M. R., Regasini, L. O., Simote, S. Y., Lopes, N. P., Pirani, J. R., Bolzani, V. D. S., & Young, M. C. M. (2010) · Molecules · doi:10.3390/molecules15129205 · Cited by 80
N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum
Berkov, S. H., Codina, C. J., Viladomat, F., & Bastida, J. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.008 · Cited by 78
Anti-Alzheimer’s disease activity of compounds from the root bark of Morus alba L.
Kuk, E. B., Jo, A. R., Oh, S. I., Sohn, H. S., Seong, S. H., Roy, A., Choi, J. S., & Jung, H. A. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0891-4 · Cited by 77
Reza, A. S. M. A., Hossain, M. S., Akhter, S., Rahman, M. R., Nasrin, S., Uddin, M. J., Sadik, G., & Alam, A. H. M. K. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2182-0 · Cited by 76
BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos
Jung, H. A., Karki, S., Kim, J. H., et al. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0492-4 · Cited by 74
Lin, H., Ho, M. T., Lau, L. S. K., Wong, K. K., Shaw, P., & Wan, D. C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.05.030 · Cited by 73
The progress in the cholinesterase quantification methods
Holas, O., Musílek, K., Pohanka, M., & Kuča, K. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.729037 · Cited by 70
Wong, K., Ho, M., Lin, H., et al. (2009) · Planta Medica · doi:10.1055/s-0029-1186084 · Cited by 69
Penumala, M., Zinka, R. B., Shaik, J. B., Mallepalli, S. K. R., Vadde, R., & Damu, A. G. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2140-x · Cited by 67
Loizzo, M. R., Menichini, F., Tundis, R., et al. (2009) · Journal of Oleo Science · doi:10.5650/jos.58.443 · Cited by 65
Ohba, T., Yoshino, Y., Ishisaka, M., Abe, N., Tsuruma, K., Shimazawa, M., Oyama, M., Tabira, T., & Hara, H. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1052773 · Cited by 59
Anti-diabetic and anti-Alzheimer’s disease activities of Angelica decursiva
Ali, M. Y., Jung, H. A., & Choi, J. S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0629-0 · Cited by 57
Yang, Z., Zhang, X., Du, J., Ma, Z.-J., Guo, F., Li, S., & Yao, X. (2011) · Natural Product Research · doi:10.1080/14786419.2010.487188 · Cited by 55
Lai, D.-H., Yang, Z., Xue, W., Sheng, J., Shi, Y., & Yao, X. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.06.010 · Cited by 54
Nwidu, L. L., Elmorsy, E. M., Thornton, J., Wijamunige, B. C., Wijesekara, A., Tarbox, R., Warren, A. Y., & Carter, W. G. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1339283 · Cited by 53
The Role of Oxidative Stress in Alzheimer ’ s Disease
Madeo, J. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000116 · Cited by 45
Bonesi, M., Loizzo, M. R., Conforti, F., PASSALACQUA, N. G., Saab, A. M., Menichini, F., & Tundis, R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12172 · Cited by 41
Armijos, C., Gilardoni, G., Amay, L., Lozano, A., Bracco, F., Ramírez, J., Bec, N., Larroque, C., Finzi, P. V., & Vidari, G. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.09.049 · Cited by 38
Tùng, B. T., Hải, N. T., & Thu, D. K. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.037 · Cited by 34
Conforti, F., Rigano, D., Formisano, C., Bruno, M., Loizzo, M. R., Menichini, F., & Senatore, F. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903018260 · Cited by 31
Phenolic compounds from Jacaranda caroba (Vell.) A. DC.: Approaches to neurodegenerative disorders
Ferreres, F., Grosso, C., Gil‐Izquierdo, Á., Valentão, P., & Andrade, P. B. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.03.012 · Cited by 30
Gülcan, H. O., Orhan, İ. E., & Şener, B. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141202105105 · Cited by 27
Hlila, M. B., Omri, A., Jannet, H. B., Lamari, A., Aouni, M., & Selmi, B. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2012.746713 · Cited by 27
Bahloul, N., Bellili, S., Aazza, S., et al. (2016) · Antioxidants · doi:10.3390/antiox5020012 · Cited by 27
Saleem, H., Ahmad, I., Shahid, M. N., Gill, M. S. A., Nadeem, M. F., Mahmood, W., & Rashid, I. (2016) · PubMed · Cited by 18
Cited by
A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission
Phuna, Z. X., & Madhavan, P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15599 · Cited by 41
Karthivashan, G., Kweon, M.-H., Park, S.-Y., Kim, J.-S., Kim, D.-H., Ganesan, P., & Choi, D.-K. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.062 · Cited by 34
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020215 · Cited by 35
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Santos, T. C. D., Gomes, T. M., Pinto, B. A. S., Camara, A. L., & Paes, A. M. D. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-18
- Volume
- 9
- Pages
- 1192-1192
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2893930979
- Cited by
- 389
- References
- 92
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.